Global Rosuvastatin Calcium Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

Global Rosuvastatin Calcium Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030


Summary

Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation).
Rosuvastatin Calcium is a member of the drug class of statins, used in combination with exercise, diet, and weight-loss to treat high cholesterol and related conditions, and to prevent cardiovascular disease. It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body. Rosuvastatin Calcium was developed by Shionogi and has been formulated into finished oral dosage form and marketedby AstraZeneca as Crestor, Abbott Laboratories as R2.

According to APO Research, The global Rosuvastatin Calcium market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Rosuvastatin Calcium is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Rosuvastatin Calcium is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Rosuvastatin Calcium is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Rosuvastatin Calcium is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Rosuvastatin Calcium include AstraZeneca, Teva Pharmaceutical Industries, MSN Laboratories, Cadila Pharmaceuticals, LGM Pharma, Bal Pharma, Changzhou Pharmaceutical Factory, Jingxin Pharm and Zhejiang Hisun Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Rosuvastatin Calcium, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Rosuvastatin Calcium, also provides the sales of main regions and countries. Of the upcoming market potential for Rosuvastatin Calcium, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Rosuvastatin Calcium sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Rosuvastatin Calcium market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Rosuvastatin Calcium sales, projected growth trends, production technology, application and end-user industry.

Rosuvastatin Calcium segment by Company

AstraZeneca
Teva Pharmaceutical Industries
MSN Laboratories
Cadila Pharmaceuticals
LGM Pharma
Bal Pharma
Changzhou Pharmaceutical Factory
Jingxin Pharm
Zhejiang Hisun Pharmaceutical
HEC Pharm
Lunan Pharmaceutical
Nanjing Frochem Tech
Lianyungang Runzhong Pharmaceutical
Shandong Bechem Chemicals
CTX Life Sciences
Rosuvastatin Calcium segment by Type

Purity 98.0%
Purity 99.0%
Other
Rosuvastatin Calcium segment by Application

Tablet (including dispersible tablet and general tablet)
Capsule
Others
Rosuvastatin Calcium segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rosuvastatin Calcium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rosuvastatin Calcium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rosuvastatin Calcium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Rosuvastatin Calcium market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rosuvastatin Calcium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rosuvastatin Calcium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Rosuvastatin Calcium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report


1 Market Overview
1.1 Product Definition
1.2 Global Rosuvastatin Calcium Market Size, 2019 VS 2023 VS 2030
1.3 Global Rosuvastatin Calcium Market Size Estimates and Forecasts (2019-2030)
1.4 Global Rosuvastatin Calcium Sales Estimates and Forecasts (2019-2030)
1.5 Global Rosuvastatin Calcium Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Rosuvastatin Calcium Market Dynamics
2.1 Rosuvastatin Calcium Industry Trends
2.2 Rosuvastatin Calcium Industry Drivers
2.3 Rosuvastatin Calcium Industry Opportunities and Challenges
2.4 Rosuvastatin Calcium Industry Restraints
3 Rosuvastatin Calcium Market by Manufacturers
3.1 Global Rosuvastatin Calcium Revenue by Manufacturers (2019-2024)
3.2 Global Rosuvastatin Calcium Sales by Manufacturers (2019-2024)
3.3 Global Rosuvastatin Calcium Average Sales Price by Manufacturers (2019-2024)
3.4 Global Rosuvastatin Calcium Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Rosuvastatin Calcium Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Rosuvastatin Calcium Manufacturers, Product Type & Application
3.7 Global Rosuvastatin Calcium Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Rosuvastatin Calcium Market CR5 and HHI
3.8.2 Global Top 5 and 10 Rosuvastatin Calcium Players Market Share by Revenue in 2023
3.8.3 2023 Rosuvastatin Calcium Tier 1, Tier 2, and Tier 3
4 Rosuvastatin Calcium Market by Type
4.1 Rosuvastatin Calcium Type Introduction
4.1.1 Purity 98.0%
4.1.2 Purity 99.0%
4.1.3 Other
4.2 Global Rosuvastatin Calcium Sales by Type
4.2.1 Global Rosuvastatin Calcium Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Rosuvastatin Calcium Sales by Type (2019-2030)
4.2.3 Global Rosuvastatin Calcium Sales Market Share by Type (2019-2030)
4.3 Global Rosuvastatin Calcium Revenue by Type
4.3.1 Global Rosuvastatin Calcium Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Rosuvastatin Calcium Revenue by Type (2019-2030)
4.3.3 Global Rosuvastatin Calcium Revenue Market Share by Type (2019-2030)
5 Rosuvastatin Calcium Market by Application
5.1 Rosuvastatin Calcium Application Introduction
5.1.1 Tablet (including dispersible tablet and general tablet)
5.1.2 Capsule
5.1.3 Others
5.2 Global Rosuvastatin Calcium Sales by Application
5.2.1 Global Rosuvastatin Calcium Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Rosuvastatin Calcium Sales by Application (2019-2030)
5.2.3 Global Rosuvastatin Calcium Sales Market Share by Application (2019-2030)
5.3 Global Rosuvastatin Calcium Revenue by Application
5.3.1 Global Rosuvastatin Calcium Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Rosuvastatin Calcium Revenue by Application (2019-2030)
5.3.3 Global Rosuvastatin Calcium Revenue Market Share by Application (2019-2030)
6 Global Rosuvastatin Calcium Sales by Region
6.1 Global Rosuvastatin Calcium Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Rosuvastatin Calcium Sales by Region (2019-2030)
6.2.1 Global Rosuvastatin Calcium Sales by Region (2019-2024)
6.2.2 Global Rosuvastatin Calcium Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Rosuvastatin Calcium Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Rosuvastatin Calcium Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Rosuvastatin Calcium Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Rosuvastatin Calcium Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Rosuvastatin Calcium Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Rosuvastatin Calcium Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Rosuvastatin Calcium Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Rosuvastatin Calcium Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 Global Rosuvastatin Calcium Revenue by Region
7.1 Global Rosuvastatin Calcium Revenue by Region
7.1.1 Global Rosuvastatin Calcium Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Rosuvastatin Calcium Revenue by Region (2019-2024)
7.1.3 Global Rosuvastatin Calcium Revenue by Region (2025-2030)
7.1.4 Global Rosuvastatin Calcium Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Rosuvastatin Calcium Revenue (2019-2030)
7.2.2 North America Rosuvastatin Calcium Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Rosuvastatin Calcium Revenue (2019-2030)
7.3.2 Europe Rosuvastatin Calcium Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Rosuvastatin Calcium Revenue (2019-2030)
7.4.2 Asia-Pacific Rosuvastatin Calcium Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Rosuvastatin Calcium Revenue (2019-2030)
7.5.2 LAMEA Rosuvastatin Calcium Revenue Share by Country: 2019 VS 2023 VS 2030
8 Company Profiles
8.1 AstraZeneca
8.1.1 AstraZeneca Comapny Information
8.1.2 AstraZeneca Business Overview
8.1.3 AstraZeneca Rosuvastatin Calcium Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 AstraZeneca Rosuvastatin Calcium Product Portfolio
8.1.5 AstraZeneca Recent Developments
8.2 Teva Pharmaceutical Industries
8.2.1 Teva Pharmaceutical Industries Comapny Information
8.2.2 Teva Pharmaceutical Industries Business Overview
8.2.3 Teva Pharmaceutical Industries Rosuvastatin Calcium Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Teva Pharmaceutical Industries Rosuvastatin Calcium Product Portfolio
8.2.5 Teva Pharmaceutical Industries Recent Developments
8.3 MSN Laboratories
8.3.1 MSN Laboratories Comapny Information
8.3.2 MSN Laboratories Business Overview
8.3.3 MSN Laboratories Rosuvastatin Calcium Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 MSN Laboratories Rosuvastatin Calcium Product Portfolio
8.3.5 MSN Laboratories Recent Developments
8.4 Cadila Pharmaceuticals
8.4.1 Cadila Pharmaceuticals Comapny Information
8.4.2 Cadila Pharmaceuticals Business Overview
8.4.3 Cadila Pharmaceuticals Rosuvastatin Calcium Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Cadila Pharmaceuticals Rosuvastatin Calcium Product Portfolio
8.4.5 Cadila Pharmaceuticals Recent Developments
8.5 LGM Pharma
8.5.1 LGM Pharma Comapny Information
8.5.2 LGM Pharma Business Overview
8.5.3 LGM Pharma Rosuvastatin Calcium Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 LGM Pharma Rosuvastatin Calcium Product Portfolio
8.5.5 LGM Pharma Recent Developments
8.6 Bal Pharma
8.6.1 Bal Pharma Comapny Information
8.6.2 Bal Pharma Business Overview
8.6.3 Bal Pharma Rosuvastatin Calcium Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Bal Pharma Rosuvastatin Calcium Product Portfolio
8.6.5 Bal Pharma Recent Developments
8.7 Changzhou Pharmaceutical Factory
8.7.1 Changzhou Pharmaceutical Factory Comapny Information
8.7.2 Changzhou Pharmaceutical Factory Business Overview
8.7.3 Changzhou Pharmaceutical Factory Rosuvastatin Calcium Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Changzhou Pharmaceutical Factory Rosuvastatin Calcium Product Portfolio
8.7.5 Changzhou Pharmaceutical Factory Recent Developments
8.8 Jingxin Pharm
8.8.1 Jingxin Pharm Comapny Information
8.8.2 Jingxin Pharm Business Overview
8.8.3 Jingxin Pharm Rosuvastatin Calcium Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Jingxin Pharm Rosuvastatin Calcium Product Portfolio
8.8.5 Jingxin Pharm Recent Developments
8.9 Zhejiang Hisun Pharmaceutical
8.9.1 Zhejiang Hisun Pharmaceutical Comapny Information
8.9.2 Zhejiang Hisun Pharmaceutical Business Overview
8.9.3 Zhejiang Hisun Pharmaceutical Rosuvastatin Calcium Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 Zhejiang Hisun Pharmaceutical Rosuvastatin Calcium Product Portfolio
8.9.5 Zhejiang Hisun Pharmaceutical Recent Developments
8.10 HEC Pharm
8.10.1 HEC Pharm Comapny Information
8.10.2 HEC Pharm Business Overview
8.10.3 HEC Pharm Rosuvastatin Calcium Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 HEC Pharm Rosuvastatin Calcium Product Portfolio
8.10.5 HEC Pharm Recent Developments
8.11 Lunan Pharmaceutical
8.11.1 Lunan Pharmaceutical Comapny Information
8.11.2 Lunan Pharmaceutical Business Overview
8.11.3 Lunan Pharmaceutical Rosuvastatin Calcium Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Lunan Pharmaceutical Rosuvastatin Calcium Product Portfolio
8.11.5 Lunan Pharmaceutical Recent Developments
8.12 Nanjing Frochem Tech
8.12.1 Nanjing Frochem Tech Comapny Information
8.12.2 Nanjing Frochem Tech Business Overview
8.12.3 Nanjing Frochem Tech Rosuvastatin Calcium Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Nanjing Frochem Tech Rosuvastatin Calcium Product Portfolio
8.12.5 Nanjing Frochem Tech Recent Developments
8.13 Lianyungang Runzhong Pharmaceutical
8.13.1 Lianyungang Runzhong Pharmaceutical Comapny Information
8.13.2 Lianyungang Runzhong Pharmaceutical Business Overview
8.13.3 Lianyungang Runzhong Pharmaceutical Rosuvastatin Calcium Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 Lianyungang Runzhong Pharmaceutical Rosuvastatin Calcium Product Portfolio
8.13.5 Lianyungang Runzhong Pharmaceutical Recent Developments
8.14 Shandong Bechem Chemicals
8.14.1 Shandong Bechem Chemicals Comapny Information
8.14.2 Shandong Bechem Chemicals Business Overview
8.14.3 Shandong Bechem Chemicals Rosuvastatin Calcium Sales, Price, Revenue and Gross Margin (2019-2024)
8.14.4 Shandong Bechem Chemicals Rosuvastatin Calcium Product Portfolio
8.14.5 Shandong Bechem Chemicals Recent Developments
8.15 CTX Life Sciences
8.15.1 CTX Life Sciences Comapny Information
8.15.2 CTX Life Sciences Business Overview
8.15.3 CTX Life Sciences Rosuvastatin Calcium Sales, Price, Revenue and Gross Margin (2019-2024)
8.15.4 CTX Life Sciences Rosuvastatin Calcium Product Portfolio
8.15.5 CTX Life Sciences Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Rosuvastatin Calcium Value Chain Analysis
9.1.1 Rosuvastatin Calcium Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Rosuvastatin Calcium Production Mode & Process
9.2 Rosuvastatin Calcium Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Rosuvastatin Calcium Distributors
9.2.3 Rosuvastatin Calcium Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings